SjDX5-271v serves as the negative control for SjDX5-271. The compound SjDX5-271 is a 3 kDa peptide that inhibits the TLR4/MyD88/NF-kappaB signaling pathway. Additionally, SjDX5-271 induces cellular polarization, alleviates liver inflammation, and protects mice from hepatic ischemia-reperfusion injury.
Target:
NF-kappaB|||TLR
* VAT and and shipping costs not included. Errors and price changes excepted
